CBS 2019
CBSMD教育中心
中 文

动脉粥样硬化性心血管疾病预防

Abstract

Recommended Article

Effect of Evolocumab on Complex Coronary Disease Requiring Revascularization Simple Electrocardiographic Measures Improve Sudden Arrhythmic Death Prediction in Coronary Disease 2019 ACC/AHA/ASE Advanced Training Statement on Echocardiography (Revision of the 2003 ACC/AHA Clinical Competence Statement on Echocardiography): A Report of the ACC Competency Management Committee High-Risk Coronary Plaque Regression After Intensive Lifestyle Intervention in Nonbstructive Coronary Disease: A Randomized Study Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women: JACC State-of-the-Art Review Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes Long-term effects of intensive glucose lowering on cardiovascular outcomes

Guideline31 August 2019

JOURNAL:Eur Heart J. Article Link

2019 Guidelines on Diabetes, Pre-Diabetes and Cardiovascular Diseases developed in collaboration with the EASD ESC Clinical Practice Guidelines

F Cosentino, PJ Grant, ESC Scientific Document Group et al. Keywords: guidelines; diabetes mellitus; impaired glucose tolerance; cardiovascular diseases; epidemiology; risk factors; prevention; cardiovascular risk assessment; patient management; pharmacological treatment; revascularization; patient-centred care

FULL TEXT PDF